These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36458697)

  • 1. Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care.
    Avari P; Lumb A; Flanagan D; Rayman G; Misra S; Choudhary P; Dhatariya K
    J Diabetes Sci Technol; 2023 May; 17(3):625-634. PubMed ID: 36458697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous Glucose Monitoring Within Hospital: A Scoping Review and Summary of Guidelines From the Joint British Diabetes Societies for Inpatient Care.
    Avari P; Lumb A; Flanagan D; Rayman G; Misra S; Dhatariya K; Choudhary P
    J Diabetes Sci Technol; 2023 May; 17(3):611-624. PubMed ID: 36444418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of insulin pumps and closed-loop systems among people living with diabetes: A narrative review of clinical and cost-effectiveness to enable access to technology and meet the needs of payers.
    Jendle J; Reznik Y
    Diabetes Obes Metab; 2023 Jul; 25 Suppl 2():21-32. PubMed ID: 37046364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Artificial Pancreas and Type 1 Diabetes.
    Nwokolo M; Hovorka R
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1614-1623. PubMed ID: 36734145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
    Thomas MG; Avari P; Godsland IF; Lett AM; Reddy M; Oliver N
    Diabetes Obes Metab; 2021 Nov; 23(11):2521-2528. PubMed ID: 34286892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G; Jiaqi L; Liyin Z; Jianan Y; Li F; Zhiyi D; Qin Z; Xia L; Lin Y; Zhiguang Z
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
    Matsuda E; Brennan P
    JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing Patients with Insulin Pumps and Continuous Glucose Monitors in the Hospital: to Wear or Not to Wear.
    Yeh T; Yeung M; Mendelsohn Curanaj FA
    Curr Diab Rep; 2021 Jan; 21(2):7. PubMed ID: 33449214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current status of continuous subcutaneous insulin infusion and continuous glucose monitoring systems in the Community of Madrid].
    Arranz Martín A; Calle Pascual A; Del Cañizo Gómez FJ; González Albarrán O; Lisbona Gil A; Botella Serrano M; Pallardo Sánchez LF;
    Endocrinol Nutr; 2015 Apr; 62(4):171-9. PubMed ID: 25726367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
    Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attitudes and Behaviors with Diabetes Technology Use in the Hospital: Multicenter Survey Study in the United States.
    Madhun NZ; Galindo RJ; Donato J; Hwang PR; Shabir HF; Fowler MJ; Molitch-Hou E; Bena JF; Umpierrez GE; Lansang MC
    Diabetes Technol Ther; 2023 Jan; 25(1):39-49. PubMed ID: 36318781
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands.
    Serné EH; Roze S; Buompensiere MI; Valentine WJ; De Portu S; de Valk HW
    Adv Ther; 2022 Apr; 39(4):1844-1856. PubMed ID: 35226346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Technological Revolution: The Integration of New Treatments to Manage Type 1 Diabetes.
    Galderisi A; Sherr JL
    Pediatr Ann; 2019 Aug; 48(8):e311-e318. PubMed ID: 31426099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
    Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E
    Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin Problems Associated with Insulin Pumps and Sensors in Adults with Type 1 Diabetes: A Cross-Sectional Study.
    Berg AK; Nørgaard K; Thyssen JP; Zachariae C; Hommel E; Rytter K; Svensson J
    Diabetes Technol Ther; 2018 Jul; 20(7):475-482. PubMed ID: 29893593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Reactions to Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion Devices in Type 1 Diabetes Mellitus.
    Rigo RS; Levin LE; Belsito DV; Garzon MC; Gandica R; Williams KM
    J Diabetes Sci Technol; 2021 Jul; 15(4):786-791. PubMed ID: 32389062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Insulin pump therapy and continuous glucose monitoring].
    Schütz-Fuhrmann I; Rami-Merhar B; Fröhlich-Reiterer E; Hofer SE; Tauschmann M; Mader JK; Resl M; Kautzky-Willer A; Winhofer-Stöckl Y; Laimer M; Zlamal-Fortunat S; Weitgasser R
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):53-61. PubMed ID: 37101025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
    Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.